Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GE Healthcare has acquired Xcellerex, a supplier of manufacturing technologies for the fast-growing biopharmaceutical industry, to expand its offering of technologies and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines.
Subscribe to our email newsletter
The acquisition is expected to see the integration of technologies from two companies in product development and marketing to offer customer benefits through complementary product and service solutions.
GE Healthcare Life Sciences chief technology officer and vice president of BioTechnologies Nigel Darby said GE and Xcellerex together can help customers optimize every stage of their manufacturing process and has the potential to increase production flexibility and to deliver higher yields of finished product while reducing time to market.
"We believe that combining the skills of the two companies will bring great benefits for our customers in the industry," Darby said.